The Egyptian Heart Journal, published by Springer, is a premier open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. As of 2023, it holds a Q3 classification within the category, showcasing its growing influence within the research community, and ranks 241 out of 387 in Scopus, reflecting a 37th percentile position. With an E-ISSN of 2090-911X, this journal has been open access since 2011, making it easily accessible to researchers, practitioners, and students alike. The journal aims to disseminate high-quality research articles, reviews, and case studies that contribute to the understanding and treatment of cardiovascular diseases. With its focus on innovative and practical solutions in cardiology, the Egyptian Heart Journal plays a critical role in shaping current and future cardiovascular research. Its global outreach and commitment to open access ensure that vital information is available to a wide audience, enhancing both scholarly discourse and clinical practice in the evolving landscape of cardiovascular medicine.

Open Heart is a prestigious, peer-reviewed open access journal published by BMJ Publishing Group, focusing on the dynamic field of Cardiology and Cardiovascular Medicine. Launched in 2013, the journal has rapidly ascended to prominence, achieving a Q1 quartile ranking in its category as of 2023, reflecting its high-quality scholarly contributions. With an active publishing history from 2014 through 2024, Open Heart offers an expansive platform for researchers, clinicians, and students to disseminate and access groundbreaking research findings, reviews, and case studies that address critical issues in cardiovascular health. The journal is indexed in Scopus, ranking 133rd out of 387 in the Medicine - Cardiology and Cardiovascular Medicine category, placing it within the 65th percentile of its peers. Based in the United Kingdom, it promotes global research and collaboration in the cardiovascular domain, ensuring open access to vital knowledge for all stakeholders in the medical community. For access options and more information, visit the Open Heart website.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

Canadian Journal of Physiology and Pharmacology, published by Canadian Science Publishing, is a leading peer-reviewed journal dedicated to advancing knowledge in the fields of physiology and pharmacology. With an ISSN of 0008-4212 and an E-ISSN of 1205-7541, this journal has been at the forefront of biomedical research since its inception in 1964. The journal operates within a constrained access model, ensuring a selective dissemination of high-quality research, while maintaining its esteemed position in the Q3 quartile across multiple relevant categories such as Medicine, Pharmacology, and Physiology as of 2023. Researchers, professionals, and students alike will find the journal a valuable resource for emerging trends and comprehensive studies that shape contemporary science, as evidenced by its competitive Scopus rankings. The Canadian Journal of Physiology and Pharmacology is vital for fostering scholarly dialogue and innovation in the scientific community, encouraging contributions that promote a deeper understanding of physiological and pharmacological phenomena.

Baltic Journal of Art History is a prominent academic journal published by UNIV TARTU PRESS, focusing on the rich tapestry of art historical research within the Baltic region and beyond. With its ISSN 1736-8812 and E-ISSN 2346-5581, the journal serves as a vital platform for scholars, artists, and historians to disseminate innovative findings and critical analyses in the fields of History and Visual Arts and Performing Arts. Established in 2017, it has gained recognition in academic circles, achieving a Q3 ranking in History and a Q2 ranking in Visual Arts and Performing Arts as of 2023. Despite not being open access, the journal continues to attract a diverse readership eager to engage with its rigorous, peer-reviewed content. Situated in Estonia, the journal not only enriches the regional scholarly discourse but also contributes significantly to global conversations on art history. Positioned at a pivotal intersection of various disciplines, the Baltic Journal of Art History invites researchers and practitioners alike to explore the aesthetic and cultural narratives that shape our understanding of art.

Welcome to the International Journal of Angiology, a distinguished publication dedicated to advancing the field of cardiology and cardiovascular medicine. Published by THIEME MEDICAL PUBL INC, this journal plays a crucial role in disseminating innovative research and clinical insights from 1992 through 2024, serving as a vital resource for researchers, healthcare professionals, and students alike. With an ISSN of 1061-1711 and an E-ISSN of 1615-5939, the journal currently holds a respectable Q4 ranking in the cardiology field, reflecting its commitment to quality and relevance. Although it operates under a traditional access model, the journal ensures that critical research findings are shared with a broad audience, fostering collaboration and knowledge exchange. By exploring current trends, diagnostic techniques, and treatment modalities in angiology, the International Journal of Angiology remains an essential platform for those dedicated to improving cardiovascular health around the globe.

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.

JAMA Cardiology, published by the American Medical Association, is a leading peer-reviewed journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor signifying its influence and relevance within the medical community. Established in 2016, this journal has quickly gained recognition, currently positioned in the Q1 quartile and ranked #2 out of 387 in its field according to Scopus, reflecting its commitment to high-quality research dissemination. As an esteemed publication, JAMA Cardiology aims to advance the understanding of cardiovascular health through rigorous studies, reviews, and clinical insights. The journal is dedicated to serving a diverse audience of researchers, clinicians, and students, ensuring they have access to groundbreaking findings and comprehensive discussions that shape contemporary cardiology. Although it is not an open-access journal, articles published within it play a pivotal role in informing clinical practice and guiding future research in cardiovascular health, making it an essential resource for anyone engaged in this vital field.

The Journal of the American Heart Association, published by WILEY, serves as a premier platform for advancing cardiovascular medicine through its commitment to open access, fostering global dissemination of cutting-edge research since 2012. It proudly holds a prestigious position within the top quartile (Q1) in the categories of Cardiology and Cardiovascular Medicine, as evidenced by its Scopus ranking of #49 out of 387 journals, placing it in the 87th percentile. With a focus on innovative studies and transformative findings, this journal is essential for cardiologists, researchers, and healthcare professionals seeking to stay at the forefront of cardiovascular knowledge. The journal aims to bridge the gap between basic science and clinical practice, presenting findings that shape the future of heart health treatment and prevention. As a resource for academic and clinical communities alike, the Journal of the American Heart Association is dedicated to enhancing the understanding and treatment of cardiovascular diseases globally.